Literature DB >> 22370644

The molecular mechanism of microRNA-145 to suppress invasion-metastasis cascade in gastric cancer.

P Gao1, A-Y Xing, G-Y Zhou, T-G Zhang, J-P Zhang, C Gao, H Li, D-B Shi.   

Abstract

Invasion and metastasis are the major features of malignant tumors that are responsible for 90% of cancer-related deaths. Recently, microRNAs have been discovered to have a role in suppressing tumor metastasis. This study's aim was to clarify the roles of miR-145 in gastric carcinomas and its underlying molecular mechanism in regulating tumor metastasis. Here, we demonstrate a stepwise downregulation of miR-145 level in nontumorous gastric mucosa, primary gastric cancers and their secondary metastases. In vitro analysis of miR-145's ectopic expression and loss-of-function suggests that it suppresses gastric cancer cell migration and invasion. In vivo spontaneous metastasis and experimental metastasis assay further confirm its function in suppressing the invasion-metastasis cascade, including impairing local invasion and inhibiting hematogenous metastasis in gastric cancers. Furthermore, we identified a novel mechanism of miR-145 to suppress metastasis. N-cadherin (CDH2) was proved to be a direct target of miR-145, using luciferase assay and western blot. Re-expressing N-cadherin in miR-145-transfected cells reverses their migration and invasion defects. Although not a direct target of miR-145, matrix metallopeptidase 9 (MMP9), but not MMP2, was also significantly decreased in miR-145-expressing cells. We suggest that miR-145 suppresses tumor metastasis by inhibiting N-cadherin protein translation, and then indirectly downregulates its downstream effector MMP9.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22370644     DOI: 10.1038/onc.2012.61

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  81 in total

1.  Serum microRNA-145 as a novel biomarker in human ovarian cancer.

Authors:  Huichao Liang; Zhipeng Jiang; Guie Xie; Yan Lu
Journal:  Tumour Biol       Date:  2015-02-27

Review 2.  Interaction between gastric cancer stem cells and the tumor microenvironment.

Authors:  Takatsugu Ishimoto; Hiroshi Sawayama; Hidetaka Sugihara; Hideo Baba
Journal:  J Gastroenterol       Date:  2014-03-21       Impact factor: 7.527

3.  Downregulation of the Genes Involved in Reprogramming (SOX2, c-MYC, miR-302, miR-145, and P21) in Gastric Adenocarcinoma.

Authors:  Mitra Khalili; Mohammad Vasei; Davood Khalili; Kamran Alimoghaddam; Majid Sadeghizadeh; Seyed Javad Mowla
Journal:  J Gastrointest Cancer       Date:  2015-09

Review 4.  The role of microRNAs in cancers of the upper gastrointestinal tract.

Authors:  Shumei Song; Jaffer A Ajani
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-11-20       Impact factor: 46.802

Review 5.  MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer.

Authors:  C Jiang; X Chen; M Alattar; J Wei; H Liu
Journal:  Cancer Gene Ther       Date:  2015-05-22       Impact factor: 5.987

Review 6.  MicroRNA and signaling pathways in gastric cancer.

Authors:  Z Zhang; Z Li; Y Li; A Zang
Journal:  Cancer Gene Ther       Date:  2014-07-25       Impact factor: 5.987

Review 7.  Regulation of microRNAs in cancer metastasis.

Authors:  Juliette M C Bouyssou; Salomon Manier; Daisy Huynh; Samar Issa; Aldo M Roccaro; Irene M Ghobrial
Journal:  Biochim Biophys Acta       Date:  2014-02-22

8.  miR379-410 cluster miRNAs regulate neurogenesis and neuronal migration by fine-tuning N-cadherin.

Authors:  Luciano Rago; Robert Beattie; Verdon Taylor; Jennifer Winter
Journal:  EMBO J       Date:  2014-03-10       Impact factor: 11.598

9.  MiR-19a/miR-96-mediated low expression of KIF26A suppresses metastasis by regulating FAK pathway in gastric cancer.

Authors:  Ran-Ran Ma; Hui Zhang; Hong-Fang Chen; Guo-Hao Zhang; Ya-Ru Tian; Peng Gao
Journal:  Oncogene       Date:  2021-03-05       Impact factor: 9.867

10.  miR-1 and miR-145 act as tumor suppressor microRNAs in gallbladder cancer.

Authors:  Pablo Letelier; Patricia García; Pamela Leal; Héctor Álvarez; Carmen Ili; Jaime López; Jonathan Castillo; Priscilla Brebi; Juan Carlos Roa
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.